Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 1–3 of 3 recalls
Cipla USA, Inc.
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Cipla USA, Inc.
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).